Charles Bennett to Risk Assessment
This is a "connection" page, showing publications Charles Bennett has written about Risk Assessment.
Connection Strength
0.621
-
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions. Lancet Oncol. 2020 12; 21(12):e575-e588.
Score: 0.114
-
Single- versus multiple-tablet HIV regimens: adherence and hospitalization risks. Am J Manag Care. 2016 04; 22(4):242-8.
Score: 0.083
-
Consensus on the Existence of Functional Erythropoietin Receptors on Cancer Cells. JAMA Oncol. 2016 Jan; 2(1):134-6.
Score: 0.081
-
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR). J Gen Intern Med. 2012 Dec; 27(12):1697-703.
Score: 0.064
-
Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating. Leuk Lymphoma. 2009 Mar; 50(3):323-4.
Score: 0.051
-
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol. 2007 Sep 18; 50(12):1138-43.
Score: 0.046
-
Comparison and impact of COVID-19 for patients with cancer: a survival analysis of fatality rate controlling for age, sex and cancer type. BMJ Health Care Inform. 2021 May; 28(1).
Score: 0.029
-
Growth of oncology physician practice management companies. Cancer Invest. 1999; 17(5):362-70.
Score: 0.025
-
A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians. Eur Urol. 1997; 32 Suppl 3:86-8.
Score: 0.022
-
Myeloid growth factors. J Natl Compr Canc Netw. 2009 Jan; 7(1):64-83.
Score: 0.013
-
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2008 Sep; 6(8):716-53.
Score: 0.012
-
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2007 Apr 20; 25(12):1596-605.
Score: 0.011
-
Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst. 2007 Feb 07; 99(3):196-205.
Score: 0.011
-
Myeloid growth factors. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2007 Feb; 5(2):188-202.
Score: 0.011
-
Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns. 2007 Feb; 65(2):253-60.
Score: 0.011
-
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst. 2006 May 17; 98(10):708-14.
Score: 0.010
-
Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. 2005 May; 79(5):1698-703.
Score: 0.010
-
Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis. J Natl Cancer Inst. 2005 Apr 06; 97(7):489-98.
Score: 0.010
-
A rapid staging system for predicting mortality from HIV-associated community-acquired pneumonia. Chest. 2003 Apr; 123(4):1151-60.
Score: 0.008